BrevierHealth BrevierHealth
← Índice de calculadoras

D'Amico Risk Classification for Prostate Cancer

Código: 2049 · damico_risk_classification_prostate_cancer

Assesses 5 year risk of biochemical recurrence after treatment based on clinical factors.

Prognosis

Referencias

Original/Primary Reference

  1. D'Amico AV, Whittington R, Malkowicz S, et al. Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA.1998;280(11):969-974. doi:10.1001/jama.280.11.969. ↗

Other References

  1. Moul JW. The Evolving Definition of Advanced Prostate Cancer. Reviews in Urology. 2004;6(Suppl 8):S10-S17 ↗
  2. Rodrigues G, Warde P, Pickles T, et al. Pre-treatment risk stratification of prostate cancer patients: A critical review. Canadian Urological Association Journal. 2012;6(2):121-127. doi:10.5489/cuaj.11085. ↗

Validation

  1. Hernandez DJ, Nielsen ME, Han M. Contemporary evaluation of the D'amico risk classification of prostate cancer. Urology. 2007 Nov;70(5):931-5. ↗
  2. Boorjian SA, Karnes RJ, Rangel LJ. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. Epub 2008 Mar 4. ↗
  3. Lughezzani G, Budäus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy. European urology. 2010 Apr 1;57(4):562-8. ↗
  4. Koie T, Mitsuzuka K, Narita S, Yoneyama T, Kawamura S, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C. Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy. International Journal of Urology. 2015 Jan;22(1):70-3. ↗
  5. Gabriele D, Guarneri A, Bartoncini S, Munoz F, Tamponi M, Russo F, Stamatakos G, Guiot C, Regge D, Ricardi U. An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy. Radiation Oncology. 2021 May 5;16(1):85. ↗
  6. Kutluhan MA, Ünal S, Özsoy E, Şahin A, Özayar A, Okulu E, Kayıgil Ö. Evaluation of four pre‐operative models for prediction of biochemical recurrence after radical prostatectomy in localised prostate cancer. International Journal of Clinical Practice. 2021 Oct;75(10):e14682. ↗
  7. Epstein M, Syed K, Danella J, Ginzburg S, Belkoff L, Tomaszewski J, Trabulsi E, Singer EA, Jacobs BL, Raman JD, Guzzo TJ. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men. Prostate cancer and prostatic diseases. 2024 Jun;27(2):257-63. ↗